Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-26T16:33:16.024Z Has data issue: false hasContentIssue false
  • English
  • Français

Use of nutraceuticals and micronutrient supplementation for the management of Polycystic Ovary Syndrome: a scoping review

Published online by Cambridge University Press:  07 May 2024

N. Scannell ,
E. Mantzioris ,
V. Rao ,
C. Pandey ,
C. Ee ,
A. Mousa ,
L. Moran  and
A. Villani
N. Scannell
Affiliation:
School of Health, University of the Sunshine Coast, Sunshine Coast, QLD, Australia
E. Mantzioris
Affiliation:
UniSA Clinical & Health Sciences, Alliance for Research in Nutrition, Exercise and Activity (ARENA), University of South Australia, Adelaide, Australia
V. Rao
Affiliation:
NICM Health Research Institute, Western Sydney University, Sydney, Australia
C. Pandey
Affiliation:
Monash Centre for Health Research and Implementation (MCHRI), School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
C. Ee
Affiliation:
NICM Health Research Institute, Western Sydney University, Sydney, Australia
A. Mousa
Affiliation:
Monash Centre for Health Research and Implementation (MCHRI), School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
L. Moran
Affiliation:
Monash Centre for Health Research and Implementation (MCHRI), School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
A. Villani
Affiliation:
School of Health, University of the Sunshine Coast, Sunshine Coast, QLD, Australia
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Polycystic Ovary Syndrome (PCOS) is a common hormonal condition affecting women of reproductive age(1). Women with PCOS experience a broad range of clinical symptoms, collectively grouped into reproductive, metabolic, psychological and anthropometric features(2). Complementary therapies, such as nutrient supplementation, have been identified as potential adjunct therapeutic approaches to support currently recommended lifestyle and pharmacological interventions(3). However, evidence for their overall efficacy and safety is inconsistent and unclear. This review aimed to systematically map the available literature on the use of nutrient supplementation for the management of PCOS features, including metabolic, reproductive, psychological and anthropometric. This review followed a systematic approach with literature searches using CINHAL, Cochrane reviews, Medline, PsycINFO, Scopus and LILACS conducted up to April 2022. All types of study designs were included if they reported on the efficacy or association between micronutrient supplementation and/or nutraceuticals on features of PCOS in women (≥ 18 years) with a confirmed diagnosis of PCOS. A total of 317 articles were included involving n = 23,926 women. Forty-three different supplements examined various clinical features of PCOS grouped into metabolic, reproductive, psychological and anthropometric. The most studied supplements included Inositols (n = 83), Vitamin D (n = 51), N-acetylcysteine (n = 25), Omega-3 fatty acids (n = 18) and Biotics (n = 14). Most studies (n = 262; 83%) reported on reproductive features followed by metabolic (n = 212; 66%), anthropometric (n = 181; 57%) and psychological (n = 5; 2%). Less than half (n = 148; 47%) of the included studies reported on the potential for adverse events. Our results highlight that the potential therapeutic benefit of micronutrient and nutraceutical supplementation on psychological features of PCOS warrants future exploration. Additional primary studies that are adequately powered are needed to investigate therapeutic doses needed for clinical benefits. Lastly, a more rigorous approach to monitoring and recording adverse event data is recommended.

Keywords

Polycystic Ovary Syndromenutraceuticalssupplementationmicronutrients
Type
Abstract
Information
Proceedings of the Nutrition Society , Volume 83 , Issue OCE1: The 57th Nutrition Society of New Zealand and 47th Nutrition Society of Australia Joint Annual Scientific Meeting, 28 November – 1 December 2023, Nutrition & Wellbeing in Oceania , April 2024 , E176
Check for updates
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Nutrition Society

References

Bozdag, G, Mumusoglu, S et al. (2016) Human Repro 31, 2841–2855.CrossRefGoogle Scholar
Teede, H, Deeks, A et al. (2010) BMC Med 8, 1–10.CrossRefGoogle Scholar
Bergamin, A, Mantzioris, E (2019) Pharm Med 33, 291–309.CrossRefGoogle Scholar